SCHEMBL843624

SCHEMBL843624

COP(=O)(OC)C(C)(NC(C)=O)C(=O)O

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
HTT P42858 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1852632 0.79 MEN1 (0.37)
SCHEMBL28305379 0.77 LMNA (0.35)
SCHEMBL3178600 0.69 ALDH1A1 (0.36) L3MBTL1
SCHEMBL2489254 0.66 FDPS (0.35) L3MBTL1
SCHEMBL4087218 0.66 ALDH1A1 (0.33) L3MBTL1
SCHEMBL5665801 0.64 L3MBTL1 (0.32) L3MBTL1
SCHEMBL15647631 0.64 L3MBTL1 (0.32) L3MBTL1
SCHEMBL7670377 0.64 MAPT (0.42) MAPTL3MBTL1HTT
SCHEMBL7216621 0.63
SCHEMBL6471708 0.63 KDM4C (0.46) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432707-B1 AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN CO LLC (US) 2012-03-28 EP disclosed